Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Offers HRAM Library for Environmental, Food Safety, Clinical Research, Toxicology

Published: Thursday, June 19, 2014
Last Updated: Thursday, June 19, 2014
Bookmark and Share
30,000 MS/MS spectra for 2,000 compounds boost confidence in results, method flexibility

Laboratories analyzing environmental, clinical research/toxicological, and food samples have a powerful new data tool expected to save time and money while identifying compounds with high levels of confidence. 

Thermo Fisher Scientific has announced its high resolution accurate mass (HRAM) spectral library.

“This is a true library with full, high-resolution spectra for every compound it contains,” said Jennifer Massi, program manager, environmental and food safety for Thermo Fisher Scientific. “In fact, we ran multiple MS/MS spectra for each compound, and each was analyzed at multiple collision energies. This is designed to enhance method flexibility and confidence in results.”

The library was generated using the Thermo Scientific Q Exactive liquid chromatography-mass spectrometry (LC-MS) system at 140,000 resolution to minimize false positives and negatives as well as matrix interference. Spectra are searchable using Thermo Scientific TraceFinder software. The library contains compounds for environmental and food safety analysis that include: pesticides, mycotoxins, veterinary drugs, perfluorinated chemicals (PFCs) and other environmental contaminants. For clinical/toxicological research, it contains spectra for therapeutic and prescription drugs, illegal drugs and toxins.

The library is designed to help customers save time in method development by using defined retention times, and by searching the five most intense ions. Customers can save money because the library reduces the need to purchase standards to set up new libraries.  Method development flexibility is enhanced because spectra are generated at multiple collision energies per compound.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos